
LINK . SPRINGER . COM {
}
Title:
Comparative pharmacology of human adenosine receptor subtypes – characterization of stably transfected receptors in CHO cells | Naunyn-Schmiedeberg's Archives of Pharmacology
Description:
Four adenosine receptor subtypes of the family of G protein-coupled receptors, designated A1, A2A, A2B and A3 are currently known. In this study all human subtypes were stably transfected into Chinese hamster ovary (CHO) cells in order to be able to study their pharmacological profile in an identical cellular background utilizing radioligand binding studies (A1, A2A, A3) or adenylyl cyclase activity assays (A2B). The A1 subtype showed the typical pharmacological profile with 2-chloro-N6-cyclopentyladenosine (CCPA) as the agonist with the highest affinity and a marked stereoselectivity for the N6-phenylisopropyladenosine (PIA) diastereomers. In competition with antagonist radioligand biphasic curves were observed for agonists. In the presence of GTP all receptors were converted to a single low affinity state indicating functional coupling to endogenous G proteins. For A2A adenosine receptors CGS 21680 (2-[p-(2-carboxyethyl)phenylethylamino]-5′-N-ethylcarboxamidoadenosine) and N-ethylcarboxamidoadenosine (NECA) were found to be the most potent agonists followed by R- and S-PIA with minor stereoselectivity. The relative potencies of agonists for the A2B adenosine receptor could only be tested by measurement of receptor-stimulated adenylyl cyclase activity. NECA was the most potent agonist with an EC50-value of 2.3 μM whereas all other compounds tested were active at concentrations in the high micromolar range. Inhibition of NECA-stimulated adenylyl cyclase identified xanthine amino congener (XAC; 8-[4-[[[[(2-aminoethyl)amino]carbonyl]methyl]oxy]phenyl]-1,3-dipropylxanthine) as the most potent antagonist at this receptor subtype. The A3 receptor was characterized utilizing the nonselective agonist [3H]NECA. The N6-benzyl substituted derivatives of adenosine-5′-N-methyluronamide (MECA) turned out to be the most potent agonists. The notion of xanthine-insensitivity of the A3 receptor should be dropped at least for the human receptor as xanthines with submicromolar affinity were found. Overall, the pharmacological characteristics of the human receptors are similar to other species with some species-specific characteristics. In this study we present for the first time the comparative pharmacology of all known human adenosine receptor subtypes. The CHO cells with stably transfected adenosine receptors provide an identical cellular background for such a pharmacological characterization. These cells are valuable systems for further characterization of specific receptor subtypes and for the development of new ligands.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Non-Profit & Charity
- Science
- Telecommunications
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We can't tell how the site generates income.
Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com might be cashing in, but we can't detect the method they're using.
Keywords {🔍}
receptors, adenosine, article, receptor, pharmacology, human, subtypes, privacy, cookies, content, cells, information, publish, research, search, characterization, stably, transfected, cho, pharmacological, agonists, potent, access, data, log, journal, naunynschmiedebergs, comparative, klotz, hessling, hegler, proteincoupled, study, adenylyl, cyclase, agonist, affinity, discover, springer, optional, personal, parties, policy, find, track, archives, cite, owman, kull, fredholm,
Topics {✒️}
protein-coupled receptors amino]carbonyl]methyl]oxy]phenyl]-1 month download article/chapter n6-benzyl substituted derivatives identical cellular background nonselective agonist [3h]neca related subjects peripheral adenosine receptors stably transfected receptors a2b adenosine receptor adenosine receptor subtypes privacy choices/manage cookies article naunyn-schmiedeberg' medical cell research specific receptor subtypes full article pdf a1 subtype showed adenosine receptors human receptors adenosine-5′-n-methyluronamide european economic area scope submit manuscript chinese hamster ovary 2-chloro-n6-cyclopentyladenosine high micromolar range hippocampal synaptic transmission equilibrative nucleoside transporters conditions privacy policy phenylethylamino]-5′-n-ethylcarboxamidoadenosine accepting optional cookies a3 receptor check access instant access typical pharmacological profile main content log human receptor species-specific characteristics journal finder publish naunyn-schmiedeberg' human subtypes xanthine-insensitivity comparative pharmacology designated a1 receptor subtype stably transfected characterized utilizing pharmacology aims receptors article log privacy policy
Schema {🗺️}
WebPage:
mainEntity:
headline:Comparative pharmacology of human adenosine receptor subtypes – characterization of stably transfected receptors in CHO cells
description: Four adenosine receptor subtypes of the family of G protein-coupled receptors, designated A1, A2A, A2B and A3 are currently known. In this study all human subtypes were stably transfected into Chinese hamster ovary (CHO) cells in order to be able to study their pharmacological profile in an identical cellular background utilizing radioligand binding studies (A1, A2A, A3) or adenylyl cyclase activity assays (A2B). The A1 subtype showed the typical pharmacological profile with 2-chloro-N6-cyclopentyladenosine (CCPA) as the agonist with the highest affinity and a marked stereoselectivity for the N6-phenylisopropyladenosine (PIA) diastereomers. In competition with antagonist radioligand biphasic curves were observed for agonists. In the presence of GTP all receptors were converted to a single low affinity state indicating functional coupling to endogenous G proteins. For A2A adenosine receptors CGS 21680 (2-[p-(2-carboxyethyl)phenylethylamino]-5′-N-ethylcarboxamidoadenosine) and N-ethylcarboxamidoadenosine (NECA) were found to be the most potent agonists followed by R- and S-PIA with minor stereoselectivity. The relative potencies of agonists for the A2B adenosine receptor could only be tested by measurement of receptor-stimulated adenylyl cyclase activity. NECA was the most potent agonist with an EC50-value of 2.3 μM whereas all other compounds tested were active at concentrations in the high micromolar range. Inhibition of NECA-stimulated adenylyl cyclase identified xanthine amino congener (XAC; 8-[4-[[[[(2-aminoethyl)amino]carbonyl]methyl]oxy]phenyl]-1,3-dipropylxanthine) as the most potent antagonist at this receptor subtype. The A3 receptor was characterized utilizing the nonselective agonist [3H]NECA. The N6-benzyl substituted derivatives of adenosine-5′-N-methyluronamide (MECA) turned out to be the most potent agonists. The notion of xanthine-insensitivity of the A3 receptor should be dropped at least for the human receptor as xanthines with submicromolar affinity were found. Overall, the pharmacological characteristics of the human receptors are similar to other species with some species-specific characteristics. In this study we present for the first time the comparative pharmacology of all known human adenosine receptor subtypes. The CHO cells with stably transfected adenosine receptors provide an identical cellular background for such a pharmacological characterization. These cells are valuable systems for further characterization of specific receptor subtypes and for the development of new ligands.
datePublished:
dateModified:
pageStart:1
pageEnd:9
sameAs:https://doi.org/10.1007/PL00005131
keywords:
Key words Adenosine receptors
G protein-coupled
receptors
Stable transfection
Signal transduction
A1
A2A
A2B
A3
ligand
Pharmacology/Toxicology
Neurosciences
image:
isPartOf:
name:Naunyn-Schmiedeberg's Archives of Pharmacology
issn:
1432-1912
0028-1298
volumeNumber:357
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:K.-N. Klotz
affiliation:
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany
address:
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany, , DE
type:PostalAddress
type:Organization
type:Person
name:J. Hessling
affiliation:
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany
address:
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany, , DE
type:PostalAddress
type:Organization
type:Person
name:J. Hegler
affiliation:
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany
address:
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany, , DE
type:PostalAddress
type:Organization
type:Person
name:C. Owman
affiliation:
name:Department of Medical Cell Research, University of Lund, S-22362 Lund, Sweden
address:
name:Department of Medical Cell Research, University of Lund, S-22362 Lund, Sweden, , SE
type:PostalAddress
type:Organization
type:Person
name:B. Kull
affiliation:
name:Department of Physiology and Pharmacology, Karolinska Institute, S-17177 Stockholm, Sweden
address:
name:Department of Physiology and Pharmacology, Karolinska Institute, S-17177 Stockholm, Sweden, , SE
type:PostalAddress
type:Organization
type:Person
name:B. B. Fredholm
affiliation:
name:Department of Physiology and Pharmacology, Karolinska Institute, S-17177 Stockholm, Sweden
address:
name:Department of Physiology and Pharmacology, Karolinska Institute, S-17177 Stockholm, Sweden, , SE
type:PostalAddress
type:Organization
type:Person
name:M. J. Lohse
affiliation:
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany
address:
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany, , DE
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Comparative pharmacology of human adenosine receptor subtypes – characterization of stably transfected receptors in CHO cells
description: Four adenosine receptor subtypes of the family of G protein-coupled receptors, designated A1, A2A, A2B and A3 are currently known. In this study all human subtypes were stably transfected into Chinese hamster ovary (CHO) cells in order to be able to study their pharmacological profile in an identical cellular background utilizing radioligand binding studies (A1, A2A, A3) or adenylyl cyclase activity assays (A2B). The A1 subtype showed the typical pharmacological profile with 2-chloro-N6-cyclopentyladenosine (CCPA) as the agonist with the highest affinity and a marked stereoselectivity for the N6-phenylisopropyladenosine (PIA) diastereomers. In competition with antagonist radioligand biphasic curves were observed for agonists. In the presence of GTP all receptors were converted to a single low affinity state indicating functional coupling to endogenous G proteins. For A2A adenosine receptors CGS 21680 (2-[p-(2-carboxyethyl)phenylethylamino]-5′-N-ethylcarboxamidoadenosine) and N-ethylcarboxamidoadenosine (NECA) were found to be the most potent agonists followed by R- and S-PIA with minor stereoselectivity. The relative potencies of agonists for the A2B adenosine receptor could only be tested by measurement of receptor-stimulated adenylyl cyclase activity. NECA was the most potent agonist with an EC50-value of 2.3 μM whereas all other compounds tested were active at concentrations in the high micromolar range. Inhibition of NECA-stimulated adenylyl cyclase identified xanthine amino congener (XAC; 8-[4-[[[[(2-aminoethyl)amino]carbonyl]methyl]oxy]phenyl]-1,3-dipropylxanthine) as the most potent antagonist at this receptor subtype. The A3 receptor was characterized utilizing the nonselective agonist [3H]NECA. The N6-benzyl substituted derivatives of adenosine-5′-N-methyluronamide (MECA) turned out to be the most potent agonists. The notion of xanthine-insensitivity of the A3 receptor should be dropped at least for the human receptor as xanthines with submicromolar affinity were found. Overall, the pharmacological characteristics of the human receptors are similar to other species with some species-specific characteristics. In this study we present for the first time the comparative pharmacology of all known human adenosine receptor subtypes. The CHO cells with stably transfected adenosine receptors provide an identical cellular background for such a pharmacological characterization. These cells are valuable systems for further characterization of specific receptor subtypes and for the development of new ligands.
datePublished:
dateModified:
pageStart:1
pageEnd:9
sameAs:https://doi.org/10.1007/PL00005131
keywords:
Key words Adenosine receptors
G protein-coupled
receptors
Stable transfection
Signal transduction
A1
A2A
A2B
A3
ligand
Pharmacology/Toxicology
Neurosciences
image:
isPartOf:
name:Naunyn-Schmiedeberg's Archives of Pharmacology
issn:
1432-1912
0028-1298
volumeNumber:357
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:K.-N. Klotz
affiliation:
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany
address:
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany, , DE
type:PostalAddress
type:Organization
type:Person
name:J. Hessling
affiliation:
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany
address:
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany, , DE
type:PostalAddress
type:Organization
type:Person
name:J. Hegler
affiliation:
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany
address:
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany, , DE
type:PostalAddress
type:Organization
type:Person
name:C. Owman
affiliation:
name:Department of Medical Cell Research, University of Lund, S-22362 Lund, Sweden
address:
name:Department of Medical Cell Research, University of Lund, S-22362 Lund, Sweden, , SE
type:PostalAddress
type:Organization
type:Person
name:B. Kull
affiliation:
name:Department of Physiology and Pharmacology, Karolinska Institute, S-17177 Stockholm, Sweden
address:
name:Department of Physiology and Pharmacology, Karolinska Institute, S-17177 Stockholm, Sweden, , SE
type:PostalAddress
type:Organization
type:Person
name:B. B. Fredholm
affiliation:
name:Department of Physiology and Pharmacology, Karolinska Institute, S-17177 Stockholm, Sweden
address:
name:Department of Physiology and Pharmacology, Karolinska Institute, S-17177 Stockholm, Sweden, , SE
type:PostalAddress
type:Organization
type:Person
name:M. J. Lohse
affiliation:
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany
address:
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany, , DE
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Naunyn-Schmiedeberg's Archives of Pharmacology
issn:
1432-1912
0028-1298
volumeNumber:357
Organization:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany
address:
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany, , DE
type:PostalAddress
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany
address:
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany, , DE
type:PostalAddress
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany
address:
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany, , DE
type:PostalAddress
name:Department of Medical Cell Research, University of Lund, S-22362 Lund, Sweden
address:
name:Department of Medical Cell Research, University of Lund, S-22362 Lund, Sweden, , SE
type:PostalAddress
name:Department of Physiology and Pharmacology, Karolinska Institute, S-17177 Stockholm, Sweden
address:
name:Department of Physiology and Pharmacology, Karolinska Institute, S-17177 Stockholm, Sweden, , SE
type:PostalAddress
name:Department of Physiology and Pharmacology, Karolinska Institute, S-17177 Stockholm, Sweden
address:
name:Department of Physiology and Pharmacology, Karolinska Institute, S-17177 Stockholm, Sweden, , SE
type:PostalAddress
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany
address:
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany, , DE
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:K.-N. Klotz
affiliation:
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany
address:
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany, , DE
type:PostalAddress
type:Organization
name:J. Hessling
affiliation:
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany
address:
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany, , DE
type:PostalAddress
type:Organization
name:J. Hegler
affiliation:
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany
address:
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany, , DE
type:PostalAddress
type:Organization
name:C. Owman
affiliation:
name:Department of Medical Cell Research, University of Lund, S-22362 Lund, Sweden
address:
name:Department of Medical Cell Research, University of Lund, S-22362 Lund, Sweden, , SE
type:PostalAddress
type:Organization
name:B. Kull
affiliation:
name:Department of Physiology and Pharmacology, Karolinska Institute, S-17177 Stockholm, Sweden
address:
name:Department of Physiology and Pharmacology, Karolinska Institute, S-17177 Stockholm, Sweden, , SE
type:PostalAddress
type:Organization
name:B. B. Fredholm
affiliation:
name:Department of Physiology and Pharmacology, Karolinska Institute, S-17177 Stockholm, Sweden
address:
name:Department of Physiology and Pharmacology, Karolinska Institute, S-17177 Stockholm, Sweden, , SE
type:PostalAddress
type:Organization
name:M. J. Lohse
affiliation:
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany
address:
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany, , DE
type:PostalAddress
type:Organization
PostalAddress:
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany, , DE
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany, , DE
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany, , DE
name:Department of Medical Cell Research, University of Lund, S-22362 Lund, Sweden, , SE
name:Department of Physiology and Pharmacology, Karolinska Institute, S-17177 Stockholm, Sweden, , SE
name:Department of Physiology and Pharmacology, Karolinska Institute, S-17177 Stockholm, Sweden, , SE
name:Institut für Pharmakologie und Toxikologie, Universität Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany, , DE
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {🔗}(37)
- How much does https://www.springernature.com/gp/authors gross monthly?
- How much does https://link.springernature.com/home/ net monthly?
- Learn about the earnings of https://order.springer.com/public/cart
- What's https://submission.nature.com/new-submission/210/3's gross income?
- How much does https://www.springernature.com/gp/librarians/licensing/agc/journals pull in monthly?
- What's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=K.-N.%20Klotz?
- What's the financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22K.-N.%20Klotz%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=J.%20Hessling's financial summary
- What's the monthly income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22J.%20Hessling%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much income does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=J.%20Hegler have?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22J.%20Hegler%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate monthly?
- What is the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=C.%20Owman?
- What are the total earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22C.%20Owman%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=B.%20Kull gross monthly?
- How much income does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22B.%20Kull%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have?
- What's the financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=B.%20B.%20Fredholm?
- What's the financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22B.%20B.%20Fredholm%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=M.%20J.%20Lohse gross monthly?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22M.%20J.%20Lohse%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's revenue stream
- What's the financial intake of https://s100.copyright.com/AppDispatchServlet?title=Comparative%20pharmacology%20of%20human%20adenosine%20receptor%20subtypes%20%E2%80%93%20characterization%20of%20stably%20transfected%20receptors%20in%20CHO%20cells&author=K.-N.%20Klotz%20et%20al&contentID=10.1007%2FPL00005131©right=Springer-Verlag%20Berlin%20Heidelberg&publication=0028-1298&publicationDate=1997-12&publisherName=SpringerNature&orderBeanReset=true?
- How much does https://citation-needed.springer.com/v2/references/10.1007/PL00005131?format=refman&flavour=citation make?
- See how much https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral makes per month
- How much profit does https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research make?
- How much does https://www.springernature.com/gp/products rake in every month?
- What's the monthly money flow for https://www.springernature.com/gp/librarians?
- What's the income of https://www.springernature.com/gp/societies?
- What's the financial intake of https://www.springernature.com/gp/partners?
- Learn how profitable https://www.springer.com/ is on a monthly basis
- How much money does https://www.nature.com/ generate?
- How much does https://www.biomedcentral.com/ generate monthly?
- How much does https://www.palgrave.com/ make?
- Learn about the earnings of https://www.apress.com/
- Earnings of https://www.springernature.com/gp/legal/ccpa
- How much does https://www.springernature.com/gp/info/accessibility pull in?
- How much profit is https://support.springernature.com/en/support/home making per month?
- How profitable is https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations?
- How profitable is https://www.springernature.com/?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref